Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
EMEA Associate Director, Business Development Locations: Visp or Basel Working Pattern: Remote with 50% regular travel involved The role We are seeking an EMEA Associate Director of Business Development to drive growth across Lonza’s Specialized Modalities platform, including
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our
Overview Accountable for contributing to developing overall, cross-functional programs of a priority disease area/asset, focused on shaping assets with strong commercial potential in line with TA priorities. (Global) Provides direction and functional expertise in a cross-functional